|
|
Post by novafett on Jul 30, 2015 11:51:49 GMT -5
Haha yea i pulled up yahoo finance MNKD earlier today to see the price down but was too busy to buy in again (bought some yesterday on the "refinance" deal). Figured I'd come back this afternoon and take another dip. The price has all but recovered (-.02)!! Guess early bird gets that wormy.  |
|
|
|
Post by bradleysbest on Jul 30, 2015 11:52:00 GMT -5
Agree with you that it is short covering.
|
|
|
|
Post by newmnkdinvestor on Jul 30, 2015 11:59:56 GMT -5
Some days I think the MNKD longs conspiracy is a little much but to go down 10% and be flat has left me puzzled.
|
|
|
|
Post by dreamboatcruise on Jul 30, 2015 12:00:32 GMT -5
Haha yea i pulled up yahoo finance MNKD earlier today to see the price down but was too busy to buy in again (bought some yesterday on the "refinance" deal). Figured I'd come back this afternoon and take another dip. The price has all but recovered (-.02)!! Guess early bird gets that wormy. The early lizard did this morning. Hopefully the worms don't cause delayed indigestion come tomorrow's script numbers. It was my plan to buy today... gotta stick to the plan. |
|
|
|
Post by charlespk on Jul 30, 2015 12:06:42 GMT -5
I stayed up last night to get a glance at the press release , and then I posted. Luckily i live in California so not that late .
My comment then after the 3 million euro in the second quarter, was that in the morning they would clobber the PPS which they did .
I agree that once they lowered it enough , some short covering started , this has been their long term plan all along , with The PPS back at $ 4.44 i think its a combination of short covering , institutional buying , day traders who will make a quick profit in one day and some longs adding to their positions when it hit low 4's.
Just wish we knew how much in each category .
This time it meant that bad news , made PPS come back up ( the reverse of the usual ) , unless they bring it down at the close today .
I am in it for the long haul , like many on this board , like I said last night this will take a year or so, before we start going up exponentially
|
|
|
|
Post by nylefty on Jul 30, 2015 12:13:24 GMT -5
Goes back to the idea that maybe they can't head for the exits if the majority of the position is one large HF. See my post in the SI thread yesterday...issues with too big to exit thesis. I have no idea what "one large HF" means. Please excuse my ignorance and explain. |
|
|
|
Post by BD on Jul 30, 2015 12:14:52 GMT -5
Hedge Fund, lefty.
|
|
|
|
Post by obamayoumama on Jul 30, 2015 12:27:50 GMT -5
Merrill needs to cover 9 million share. I believe we are seeing the beginning of this. |
|
|
|
Post by parrerob on Jul 30, 2015 12:55:18 GMT -5
Merrill needs to cover 9 million share. I believe we are seeing the beginning of this. And I think the 4.44/4.45 level is very significant now.... take a look at yesterday and today's too..... very very strange...... 7% down then stopped at that level with no more movements (for hours) even if good volume. Today seems the same....... what's happening at this level ? Quite sure it is linked to the 9 millions shares to be returned and to the low dilution planned..... do we have to expect 10 days at 4.44/4.45 (except the first 2 trading hours)? |
|
|
|
Post by centralcoastinvestor on Jul 30, 2015 13:06:41 GMT -5
Merrill needs to cover 9 million share. I believe we are seeing the beginning of this. And I think the 4.44/4.45 level is very significant now.... take a look at yesterday and today's too..... very very strange...... 7% down then stopped at that level with no more movements (for hours) even if good volume. Today seems the same....... what's happening at this level ? Quite sure it is linked to the 9 millions shares to be returned and to the low dilution planned..... do we have to expect 10 days at 4.44/4.45 (except the first 2 trading hours)? One thing really baffles me. Whose shares is everyone buying? If shorts are covering, institutions accumulating, longs buying, who the heck is selling? I can't imagine there are enough shares from disillusioned longs selling to make a dent in all of this. |
|
|
|
Post by patryn on Jul 30, 2015 13:12:29 GMT -5
And I think the 4.44/4.45 level is very significant now.... take a look at yesterday and today's too..... very very strange...... 7% down then stopped at that level with no more movements (for hours) even if good volume. Today seems the same....... what's happening at this level ? Quite sure it is linked to the 9 millions shares to be returned and to the low dilution planned..... do we have to expect 10 days at 4.44/4.45 (except the first 2 trading hours)? One thing really baffles me. Whose shares is everyone buying? If shorts are covering, institutions accumulating, longs buying, who the heck is selling? I can't imagine there are enough shares from disillusioned longs selling to make a dent in all of this. There are probably some margin calls that got triggered. The volume is not really that high. We're not seeing multiples of the daily average in volume so all of this is just minor blips in traded shares. As for who else might be selling, it is possible that there are some investors who jumped in around the 6's and can't stomach a 25% loss and are cutting bait? |
|
|
|
Post by rockstarrick on Jul 30, 2015 14:05:53 GMT -5
But they spoke about Afrezza in Q1...That explanation doesn't fit the bill. Don't think I'm a newbie to this stock, btw. I've contribute multiple bullish articles on Seeking Alpha for these guys Yes, they did speak about Afrezza in qtr1CC. I wonder what has changed ?? They spoke in detail about their new injectable prandial insulin and even claimed it to be superior to existing RAA's. They also mentioned Genzyme and Regeneron, but said nothing of Mannkind or Afrezza. No discussion on DTC, 2nd phase launch, absolutely not one word. |
|
|
|
Post by babaoriley on Jul 30, 2015 15:55:09 GMT -5
Does anyone find it hilarious within this thread entitle, "Short covering in process now" that nobody is talking about shorts covering? Unlike most days when my peers are posting "they're covering!", the share price is actually slowly climbing higher after the early morning knock-down, which indicates buying. It sure looks like some covering may be in the mix, but with a volume of 5.5 million as I type this, one would hardly state that shorts are heading for the exits. Okay, back to the off-topic banter... mn, I really do think a few short shares got covered this morning, as we rose from the dead; it would be too good to be true to expect them to all head out at once. But maybe 2 or 3 million covered today, at a nice price for them, unfortunately. |
|
|
|
Post by babaoriley on Jul 30, 2015 15:59:02 GMT -5
And I think the 4.44/4.45 level is very significant now.... take a look at yesterday and today's too..... very very strange...... 7% down then stopped at that level with no more movements (for hours) even if good volume. Today seems the same....... what's happening at this level ? Quite sure it is linked to the 9 millions shares to be returned and to the low dilution planned..... do we have to expect 10 days at 4.44/4.45 (except the first 2 trading hours)? One thing really baffles me. Whose shares is everyone buying? If shorts are covering, institutions accumulating, longs buying, who the heck is selling? I can't imagine there are enough shares from disillusioned longs selling to make a dent in all of this. If you read all the posts lately, I think you'll find a disillusioned long or two, CCI. And others had to sell some due to margin calls (myself included, it wasn't too bad for me, but I sold some shares rather than put up more cash). |
|
|
|
Post by babaoriley on Jul 30, 2015 16:01:48 GMT -5
But they spoke about Afrezza in Q1...That explanation doesn't fit the bill. Don't think I'm a newbie to this stock, btw. I've contribute multiple bullish articles on Seeking Alpha for these guys Yes, they did speak about Afrezza in qtr1CC. I wonder what has changed ?? They spoke in detail about their new injectable prandial insulin and even claimed it to be superior to existing RAA's. They also mentioned Genzyme and Regeneron, but said nothing of Mannkind or Afrezza. No discussion on DTC, 2nd phase launch, absolutely not one word. Would have been nice to get at least a small bone thrown our way, but we'll have to live with it. Of course, they may have felt why draw attention to a drug with a couple of million euros of sales, for a huge company, that might strike a discordant note with some of their big shareholders or analysts. |
|
